X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.fiercepharma.com/pharma/novartis-isnt-done-shaking-things-sells-five-eyecare-drugs-harrow-130-million
https://www.pharmacompass.com/pdf/news/imprimis-njof-llc-receives-fda-warning-letter-1562735073.pdf
https://www.businesswire.com/news/home/20190507005004/en/Mati-Therapeutics-Phase-II-Nepafenac-Evolute%C2%AE-Clinical/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==
https://www.businesswire.com/news/home/20180904005058/en/Mati-Therapeutics-Interim-Phase-II-Nepafenac-Clinical
https://www.tga.gov.au/prescription-medicines-new-or-extended-uses-registered-medicines
https://www.pharmacompass.com/pdf/news/Imprimis-Pharmaceuticals-Receives-FDA-Warning-Letter-1516167417.pdf
http://www.prnewswire.com/news-releases/imprimis-pharmaceuticals-announces-plans-to-launch-iv-free-conscious-sedation-and-new-compounded-triple-drop-formulations-at-leading-cataract-and-refractive-surgeons-meeting-300263518.html
Market Place
Share 
